Sharon Vered Email
VP CMC . NeuroSense Therapeutics
Cambridge, MA
LocationPrimary Email
How to contact Sharon Vered
Join and see Sharon's contact info for free!Current Roles
Employees:
34Revenue:
$5.3MAbout
Advancing research, development and therapy for ALS and additional CNS indications.\n\nNeuroSense Therapeutics Ltd. (NASDAQ: NRSN) is a clinical stage Biotech company focusing on the development of a ground-breaking treatment for ALS patients, as well as other neurodegenerative diseases.\n\nCurrently in conducting a Phase 2b, double-blind, randomized, placebo controlled clinical study in ALS patients globally.\n$NRSNNeuroSense Therapeutics Address
Cambridge, MA
IL